Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy

American Journal of Transplantation

Volumn 14, Issue 3, 2014, Pages 685-693

  Angaswamy, N ^a   Klein, C ^a   Tiriveedhi, V ^a,c   Gaut, J ^a   Anwar, S ^a   Rossi, A ^a   Phelan, D ^b   Wellen, J R ^a   Shenoy, S ^a   Chapman, W C ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Alloimmunity; autoimmunity; Collagen IV; fibronectin; kidney transplantation; transplant glomerulopathy

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 17;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GLOMERULOPATHY; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSPLANT GLOMERULOPATHY;

ALLOIMMUNITY; AUTOIMMUNITY; COLLAGEN-IV; FIBRONECTIN; KIDNEY TRANSPLANTATION; TRANSPLANT GLOMERULOPATHY;

AUTOANTIBODIES; AUTOANTIGENS; COLLAGEN TYPE IV; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRONECTINS; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; ISOANTIBODIES; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84896720085     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12592     Document Type: Article

References (26)

1. Husain S, Sis B., Advances in the understanding of transplant glomerulopathy. Am J Kidney Dis 2013; 62: 352-363.
2. Tiriveedhi V, Sarma N, Mohanakumar T., An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection. Int J Immunogenet 2012; 39: 373-380.
3. Dragun D, Muller DN, Brasen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569.
4. Giral M, Foucher Y, Dufay A, et al. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant 2013; 13: 2567-2576.
5. Joosten SA, van Dixhoorn MG, Borrias MC, et al. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol 2002; 160: 1301-1310.
6. Strom EH, Banfi G, Krapf R, et al. Glomerulopathy associated with predominant fibronectin deposits: A newly recognized hereditary disease. Kidney Int 1995; 48: 163-170.
7. Colvin RB., Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056.
8. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: Subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124-2132.
9. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743-1752.
10. Ivanyi B., Transplant capillaropathy and transplant glomerulopathy: Ultrastructural markers of chronic renal allograft rejection. Nephrol Dial Transplant 2003; 18: 655-660.
11. Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T., Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: A 30-month analysis in living donor kidney transplantation. Hum Immunol 2010; 71: 268-273.
12. Borg BB, Seetharam A, Subramanian V, et al. Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transplant 2011; 17: 814-823.
13. Saini D, Weber J, Ramachandran S, et al. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant 2011; 30: 624-631.
14. Veronese FV, Manfro RC, Roman FR, et al. Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant 2005; 19: 518-521.
15. Li C, Yang CW., The pathogenesis and treatment of chronic allograft nephropathy. Nat Rev Nephrol 2009; 5: 513-519.
16. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68-74.
17. Shu KH, Lu YS, Chang CH, et al. Transplant glomerulopathy-A clinicopathological study. Transplant Proc 1996; 28: 1527-1528.
18. Kupin W, Nakhleh R, Lee M, et al. Separate risk factors for the development of transplant glomerulopathy vs chronic tubulointerstitial rejection. Transplant Proc 1997; 29: 245-246.
19. Mao Q, Terasaki PI, Cai J, et al. Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant 2007; 7: 864-871.
20. Campos EF, Tedesco-Silva H, Machado PG, Franco M, Medina-Pestana JO, Gerbase-DeLima M., Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 2006; 6: 2316-2320.
21. Al-Muhsen S, Letuve S, Vazquez-Tello A, et al. Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils. Respir Res 2013; 14: 34-44.
22. Sellares J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12: 388-399.
23. Dinavahi R, George A, Tretin A, et al. Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol 2011; 22: 1168-1178.
24. Cosio FG, Gloor JM, Sethi S, Stegall MD., Transplant glomerulopathy. Am J Transplant 2008; 8: 492-496.
25. Hachem RR, Yusen RD, Meyers BF, et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 2010; 29: 973-980.
26. Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T., Antibodies to K-alpha 1 tubulin and Collagen V are associated with chronic rejection after lung transplantation. Am J Transplant 2012; 12: 2164-2171.